Introduction: Mycophenolate mofetil (MMF) or enteric coated mycophenolate sodium (EC-MPS) and steroids are used for induction and maintenance therapy in severe lupus nephritis (LN). Blood concentrations of mycophenolic acid (MPA), the active metabolite of these A C C E P T E D C o p y r i g h t © 2 0 1 T h e A u t h o r ( s ) . P u b l i s h e d b y W o l t e r s K l u w e r H e a l t h , I n c . o nb e h a l fo ft h eI n t e r n a t i o n a lA s s o c i a t i o no f T h e r a p e u t i cD r u gM o n i t o r i n ga n dC l i n i c a lT o x i c o l o g y

Although recalculating digoxin concentrations measured during 2009 to their corrected values produced a significant change in concentration and values inside and outside the range, this does not seem to have had an influence on patient treatment. Rather, clinicians tended to use the clinical impression to dose digoxin.

No abstract

No abstract